Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Articles by Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Latest Updated Articles
- Study Summary: Cabozantinib for Advanced and Progressing Hepatocellular Carcinoma
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
2
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
3
Nimbus Therapeutics, Eli Lilly Partner to Develop Novel Oral Metabolic Drug
4
Telemedicine Utilization and Preventive Services Among a Rural Population
5
